Ph+ ALL patients in first complete remission have similar survival after reduced intensity and myeloablative allogeneic transplantation: Impact of tyrosine kinase inhibitor and minimal residual disease
暂无分享,去创建一个
M. Norkin | R. Vij | M. Aljurf | A. Miller | I. Lewis | R. Gale | J. Pidala | J. Liesveld | H. Lazarus | J. Rowe | D. Weisdorf | E. Waller | V. Bachanova | M. Arellano | Yi-Bin Chen | E. Copelan | M. Litzow | Vikas Gupta | M. de Lima | A. Artz | J. Greer | A. Loren | D. Marks | B. Savani | W. Saber | H. Wang | M-J Zhang | P. Wiernik | P. Kebriaei | B. Oran | J. Cahn | G. Hale | Mei-Jie Zhang | W. Drobyski | M. Litzow | U. Bacher | Hai-lin Wang | V. Lewis | V. Gupta | Y-B Chen | Jean-Yves Cahn | A. Miller | J. Cahn